DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Novavax, Inc. (NVAX)
« Back to company indexNVAX Chatter Timeline
Stock Ticker for NVAX
Most Active Tweeters for NVAX
| User | Tweets |
|---|---|
| @Tickeron | 13 |
| @tabuhasna | 11 |
| @AmericanBanking | 5 |
| @TranscriptDaily | 5 |
| @ZolmaxNews | 3 |
Recent Tweets for NVAX
 |
@tabuhasna RT @OlympiaReport: $4.40 Million in Sales Expected for Novavax, Inc. $NVAX This Quarter https://t.co/Z4SBLBgJKj October 21st 2019, 5:10pm |
 |
@TheMarketsDaily -$0.91 EPS Expected for Novavax, Inc. $NVAX This Quarter https://t.co/KQtw50ew1I October 21st 2019, 2:10pm |
 |
@OlympiaReport $4.40 Million in Sales Expected for Novavax, Inc. $NVAX This Quarter https://t.co/Z4SBLBgJKj October 21st 2019, 2:10pm |
 |
@stocknewstimes Analysts Expect Novavax, Inc. $NVAX Will Post Earnings of -$0.91 Per Share https://t.co/6exVFJppez October 21st 2019, 2:10pm |
 |
@dispatchtribune Brokerages Anticipate Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/paLSj1Wf85 October 21st 2019, 2:10pm |
 |
@BlueBioNow $NVAX here we go!! -3.02 % change recently https://t.co/Dn4wf0P8Iq October 21st 2019, 9:10am |
 |
@Tickeron $NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/GHppYNBKPD October 21st 2019, 4:10am |
|
@tabuhasna RT @OlympiaReport: Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/yBiC0V8oHM October 21st 2019, 3:10am |
|
@tabuhasna RT @bbnsnews: Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/mw0fzBOaFb October 21st 2019, 3:10am |
 |
@bbnsnews Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/mw0fzBOaFb October 21st 2019, 3:10am |
|
@OlympiaReport Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/yBiC0V8oHM October 21st 2019, 3:10am |
 |
@macondailynews Zacks Investment Research Lowers Novavax $NVAX to Sell https://t.co/sRv4nsGXLZ October 21st 2019, 2:10am |
 |
@dakotafinancial Novavax $NVAX Stock Rating Lowered by Zacks Investment Research https://t.co/iMMD1J5wAF October 21st 2019, 2:10am |
 |
@TranscriptDaily Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/xZT5YtXgGQ October 21st 2019, 2:10am |
|
@stocknewstimes Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/o5eKXMT953 October 21st 2019, 2:10am |
 |
@RatingsNetwork Cantor Fitzgerald Sets Novavax FY2019 Earnings Estimates at ($5.60) EPS. https://t.co/3xTa2F52jj $NVAX #NVAX October 21st 2019, 2:10am |
 |
@AmericanBanking Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/8vuhayNpyT #stocks October 21st 2019, 2:10am |
|
@TranscriptDaily Novavax $NVAX Rating Lowered to Sell at Zacks Investment Research https://t.co/gl8dYSjfgv October 20th 2019, 12:10pm |
|
@stocknewstimes Novavax $NVAX Downgraded by Zacks Investment Research to “Sell” https://t.co/v3yt1vCOku October 20th 2019, 12:10pm |
|
@Tickeron $NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/1y6WUJ4kbr October 20th 2019, 4:10am |
 |
@hzaben $NVAX 30 min chart. double bottom. may have finally found support at 4.40 https://t.co/m7bY1ybjrd October 20th 2019, 3:10am |
 |
@ZolmaxNews Q3 2019 EPS Estimates for Novavax, Inc. Reduced by Analyst $NVAX https://t.co/AqFUo5N7Ku October 20th 2019, 1:10am |
|
@TranscriptDaily Novavax $NVAX Receives Neutral Rating from Cantor Fitzgerald https://t.co/lcsuPV5pMr October 20th 2019, 1:10am |
|
@dispatchtribune Novavax $NVAX Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/Bb75j0ijIe October 19th 2019, 2:10pm |
 |
@WeekHerald Novavax’s $NVAX “Neutral” Rating Reaffirmed at Cantor Fitzgerald https://t.co/v2McPlB3go October 19th 2019, 2:10pm |
 |
@ThisLincolnian Novavax’s $NVAX “Neutral” Rating Reaffirmed at Cantor Fitzgerald https://t.co/pJ9D3oGbYo October 19th 2019, 2:10pm |
|
@AmericanBanking Novavax $NVAX Rating Reiterated by Cantor Fitzgerald https://t.co/QSr0bEizmw #stocks October 19th 2019, 8:10am |
|
@Tickeron $NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/xevy4d1ARz October 19th 2019, 7:10am |
|
@ZolmaxNews Analysts Anticipate Novavax, Inc. $NVAX to Post -$0.91 Earnings Per Share https://t.co/7Sv9kIpjM7 October 19th 2019, 7:10am |
 |
@TickerReport Oppenheimer Equities Analysts Decrease Earnings Estimates for Novavax, Inc. $NVAX https://t.co/nJQHKqY3aD October 19th 2019, 1:10am |
 |
@dailypoliticaln Oppenheimer Equities Analysts Decrease Earnings Estimates for Novavax, Inc. $NVAX https://t.co/CgN6F0VyM4 October 19th 2019, 1:10am |
 |
@gcassidy718 $NVAX significant stock price movement -3.24 % change recently https://t.co/P7uqhyOOBU October 18th 2019, 3:10pm |
|
@Tickeron $NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/advh8BFVK6 October 18th 2019, 10:10am |
|
@AmericanBanking Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/z8kXVvBXQ4 #stocks October 18th 2019, 6:10am |
 |
@registrarjourn Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/AggQuRhzxN October 18th 2019, 6:10am |
 |
@EnterpriseLeade Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/usNWsZRBY2 October 18th 2019, 6:10am |
|
@TranscriptDaily Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/Z0jOFjCbse October 18th 2019, 6:10am |
|
@tabuhasna RT @AmericanBanking: Analysts Expect Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/7MXuqmyeg0 #stocks October 18th 2019, 6:10am |
|
@tabuhasna RT @dakotafinancial: Zacks: Brokerages Expect Novavax, Inc. $NVAX Will Announce Quarterly Sales of $4.40 Million https://t.co/0w0jf1IVg1 October 18th 2019, 6:10am |
|
@dakotafinancial Zacks: Brokerages Expect Novavax, Inc. $NVAX Will Announce Quarterly Sales of $4.40 Million https://t.co/0w0jf1IVg1 October 18th 2019, 3:10am |
|
@AmericanBanking Analysts Expect Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/7MXuqmyeg0 #stocks October 18th 2019, 3:10am |
|
@Tickeron $NVAX in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/YTtBsz7UlY October 17th 2019, 6:10am |
|
@TranscriptDaily Novavax, Inc. $NVAX Expected to Announce Earnings of -$0.88 Per Share https://t.co/GpCfEBGEr8 October 16th 2019, 1:10pm |
|
@registrarjourn Analysts Anticipate Novavax, Inc. $NVAX to Announce -$0.88 Earnings Per Share https://t.co/nHGQTuHw0i October 16th 2019, 1:10pm |
|
@EnterpriseLeade Analysts Anticipate Novavax, Inc. $NVAX to Announce -$0.88 Earnings Per Share https://t.co/skJvtoFWRA October 16th 2019, 1:10pm |
|
@AmericanBanking Novavax, Inc. $NVAX Expected to Announce Earnings of -$0.88 Per Share https://t.co/ALwujFTo22 #stocks October 16th 2019, 1:10pm |
|
@Tickeron $NVAX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/1DZe7xiqUG October 16th 2019, 6:10am |
|
@tabuhasna RT @catfish456: NVAX - 4.69 Pre-market now at 4.69/4.84 Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza $NVAX https… October 15th 2019, 10:10am |
|
@tabuhasna RT @TekATL3: $NVAX initiates ph 3 October 15th 2019, 7:10am |
|
@tabuhasna RT @ez_alertz: $NVAX Novavax kicks off late-stage trial for new seasonal flu vaccine https://t.co/NiJ2lah8wj October 15th 2019, 7:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.